152 related articles for article (PubMed ID: 33727343)
1. Aberrant Claudin-6-Adhesion Signaling Promotes Endometrial Cancer Progression via Estrogen Receptor α.
Kojima M; Sugimoto K; Kobayashi M; Ichikawa-Tomikawa N; Kashiwagi K; Watanabe T; Soeda S; Fujimori K; Chiba H
Mol Cancer Res; 2021 Jul; 19(7):1208-1220. PubMed ID: 33727343
[TBL] [Abstract][Full Text] [Related]
2. Cell adhesion signals regulate the nuclear receptor activity.
Sugimoto K; Ichikawa-Tomikawa N; Kashiwagi K; Endo C; Tanaka S; Sawada N; Watabe T; Higashi T; Chiba H
Proc Natl Acad Sci U S A; 2019 Dec; 116(49):24600-24609. PubMed ID: 31740618
[TBL] [Abstract][Full Text] [Related]
3. The Src-Family Kinases SRC and BLK Contribute to the CLDN6-Adhesion Signaling.
Ichikawa-Tomikawa N; Sugimoto K; Kashiwagi K; Chiba H
Cells; 2023 Jun; 12(13):. PubMed ID: 37443730
[TBL] [Abstract][Full Text] [Related]
4. Upregulation of estrogen receptor mediates migration, invasion and proliferation of endometrial carcinoma cells by regulating the PI3K/AKT/mTOR pathway.
Hou X; Zhao M; Wang T; Zhang G
Oncol Rep; 2014 Mar; 31(3):1175-82. PubMed ID: 24366110
[TBL] [Abstract][Full Text] [Related]
5. Estradiol and tamoxifen induce cell migration through GPR30 and activation of focal adhesion kinase (FAK) in endometrial cancers with low or without nuclear estrogen receptor α (ERα).
Tsai CL; Wu HM; Lin CY; Lin YJ; Chao A; Wang TH; Hsueh S; Lai CH; Wang HS
PLoS One; 2013; 8(9):e72999. PubMed ID: 24039841
[TBL] [Abstract][Full Text] [Related]
6. Human phosphatidylethanolamine-binding protein 4 promotes transactivation of estrogen receptor alpha (ERalpha) in human cancer cells by inhibiting proteasome-dependent ERalpha degradation via association with Src.
Liu H; Qiu J; Li N; Chen T; Cao X
J Biol Chem; 2010 Jul; 285(29):21934-42. PubMed ID: 20460377
[TBL] [Abstract][Full Text] [Related]
7. Hypoxia-induced PLOD2 regulates invasion and epithelial-mesenchymal transition in endometrial carcinoma cells.
Wan J; Qin J; Cao Q; Hu P; Zhong C; Tu C
Genes Genomics; 2020 Mar; 42(3):317-324. PubMed ID: 31872384
[TBL] [Abstract][Full Text] [Related]
8. Knocking down FAM83B inhibits endometrial cancer cell proliferation and metastasis by silencing the PI3K/AKT/mTOR pathway.
Lin Q; Chen H; Zhang M; Xiong H; Jiang Q
Biomed Pharmacother; 2019 Jul; 115():108939. PubMed ID: 31079003
[TBL] [Abstract][Full Text] [Related]
9. Claudin-4-adhesion signaling drives breast cancer metabolism and progression via liver X receptor β.
Murakami-Nishimagi Y; Sugimoto K; Kobayashi M; Tachibana K; Kojima M; Okano M; Hashimoto Y; Saji S; Ohtake T; Chiba H
Breast Cancer Res; 2023 Apr; 25(1):41. PubMed ID: 37059993
[TBL] [Abstract][Full Text] [Related]
10. CLDN6 promotes tumor progression through the YAP1-snail1 axis in gastric cancer.
Yu S; Zhang Y; Li Q; Zhang Z; Zhao G; Xu J
Cell Death Dis; 2019 Dec; 10(12):949. PubMed ID: 31827075
[TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNA LINP1 functions as an oncogene in endometrial cancer progression by regulating the PI3K/AKT signaling pathway.
Zhang XH; Li M; Kang YJ; Xie YQ; Cao YX
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(16):6830-6838. PubMed ID: 31486482
[TBL] [Abstract][Full Text] [Related]
12. The G protein-coupled receptor GPR30 mediates the nontranscriptional effect of estrogen on the activation of PI3K/Akt pathway in endometrial cancer cells.
Ge X; Guo R; Qiao Y; Zhang Y; Lei J; Wang X; Li L; Hu D
Int J Gynecol Cancer; 2013 Jan; 23(1):52-9. PubMed ID: 23235274
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of CLDN6 inhibits cell proliferation, migration, and invasion via regulating EGFR/AKT/mTOR signalling pathway in hepatocellular carcinoma.
Huang L; Zhao C; Sun K; Yang D; Yan L; Luo D; He J; Hu X; Wang R; Shen X; Xiao N; Zhong Z
Cell Biochem Funct; 2020 Jul; 38(5):541-548. PubMed ID: 32056244
[TBL] [Abstract][Full Text] [Related]
14. A20-mediated deubiquitination of ERα in the microenvironment of CD163
Lv Q; Xie L; Cheng Y; Shi Y; Shan W; Ning C; Xie B; Yang B; Luo X; He Q; Zhu Q; Zhang Y; Zhang Z; Wang C; Chen X; Xu C
Cancer Lett; 2019 Feb; 442():137-147. PubMed ID: 30420335
[TBL] [Abstract][Full Text] [Related]
15. Macrophage ERα promoted invasion of endometrial cancer cell by mTOR/KIF5B-mediated epithelial to mesenchymal transition.
Jing X; Peng J; Dou Y; Sun J; Ma C; Wang Q; Zhang L; Luo X; Kong B; Zhang Y; Wang L; Qu X
Immunol Cell Biol; 2019 Jul; 97(6):563-576. PubMed ID: 30779215
[TBL] [Abstract][Full Text] [Related]
16. The G protein-coupled receptor GPR30 mediates the proliferative effects induced by 17beta-estradiol and hydroxytamoxifen in endometrial cancer cells.
Vivacqua A; Bonofiglio D; Recchia AG; Musti AM; Picard D; Andò S; Maggiolini M
Mol Endocrinol; 2006 Mar; 20(3):631-46. PubMed ID: 16239258
[TBL] [Abstract][Full Text] [Related]
17. Estrogen receptor β inhibits breast cancer cells migration and invasion through CLDN6-mediated autophagy.
Song P; Li Y; Dong Y; Liang Y; Qu H; Qi D; Lu Y; Jin X; Guo Y; Jia Y; Wang X; Xu W; Quan C
J Exp Clin Cancer Res; 2019 Aug; 38(1):354. PubMed ID: 31412908
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of the insulin receptor isoform A promotes endometrial carcinoma cell growth.
Wang CF; Zhang G; Zhao LJ; Qi WJ; Li XP; Wang JL; Wei LH
PLoS One; 2013; 8(8):e69001. PubMed ID: 23950881
[TBL] [Abstract][Full Text] [Related]
19. Upregulation of long non-coding RNA OGFRP1 facilitates endometrial cancer by regulating miR-124-3p/SIRT1 axis and by activating PI3K/AKT/GSK-3β pathway.
Lv Y; Chen S; Wu J; Lin R; Zhou L; Chen G; Chen H; Ke Y
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):2083-2090. PubMed ID: 31131636
[TBL] [Abstract][Full Text] [Related]
20. ER-alpha36, a variant of ER-alpha, promotes tamoxifen agonist action in endometrial cancer cells via the MAPK/ERK and PI3K/Akt pathways.
Lin SL; Yan LY; Zhang XT; Yuan J; Li M; Qiao J; Wang ZY; Sun QY
PLoS One; 2010 Feb; 5(2):e9013. PubMed ID: 20126312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
